By product, the implantable
drug delivery devices market is segmented as: Implantable
coronary drug eluting stents, implantable
contraceptive drug delivery devices, implantable
bio-absorbable stents, implantable
brachytherapy seeds, implantable
intraocular drug delivery devices, implantable
Drug Delivery Devices Market by Technology, implantable
drug infusion pumps, biodegradable implantable
drug delivery device technology, and non-biodegradable implantable
drug delivery device technology.
Thus, the treatment of SNHL with the totally implantable
hearing system appears to be an efficient and safe method for treating patients who cannot benefit from hearing aids.
As Cirtec continues to expand its business supporting the active implantable
market the addition of Core's volume manufacturing will enable our customers to grow seamlessly with Cirtec from concept to market success," said Peter Howard, CEO of Cirtec Medical Systems.
The sensor is implanted intravenously and is connected to, but does not at this time control, an implantable
insulin pump located in the abdomen.
defibrillators, they said at a press conference during the heart meeting, could help prevent many of those deaths.
Packaging and coating materials for implantable
ATLANTA -- Implantable
Provider Group (IPG) is pleased to announce a significant agreement with Blue Cross and Blue Shield of Florida, Inc.
Cardioverter Defibrillators (ICD) Revenue & Forecast - Companies Analysis (2008 - 2017) 5.
Key segments covered include Cardiac Resynchronisation Therapy - Defibrillators, Dual Chamber Implantable
Cardioverter Defibrillators and Single Chamber Implantable
The North American implantable
drug delivery devices market held majority of the market share in 2011.
Global Markets Direct's "Implantable
Cardioverter Defibrillator Clinical Trials Analysis" is an essential source of data and information pertaining to product clinical trials being carried out by Implantable
Cardioverter Defibrillator manufacturers, globally.
The Company's AbioCor(R) Implantable
Replacement Heart is now available under a Humanitarian Device Exemption granted by the United States Food and Drug Administration.
ATLANTA -- MIV Therapeutics (OTCBB:MIVT) (FWB:MIV), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable
medical devices, will hold its annual general shareholder meeting on August 24, 2006, at the Company's offices in Vancouver.
VeriChip's VeriTrace application is designed to assist state and federal agencies to plan for and manage emergency situations and disaster recovery using implantable
VeriTrace is designed to assist state and federal agencies to plan for and manage emergency situations and disaster recovery using implantable